Assessment of safety of additional transplantation of autologous bone marrow mononuclear cells in the combined treatment of coronary heart disease. Results from a randomized, blind, placebo-controlled trial (TAMIS)

Aim: to assess the safety of transplantation of autologous bone marrow mononuclear cells when performing coronary artery bypass grafting in the combined treatment of ischemic heart disease in patients with coronary and heart failure.Materials and methods. During the period from 2013 to 2016 years 11...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	V. V. Komok, N. S. Bunenkov, S. A. Beliy, V. M. Pizin, V. M. Kondratev, А. V. Dulaev, V. I. Lukashenko, A. E. Kobak, T. S. Maksimova, I. P. Sergienko, E. V. Parusova, L. A. Smirnova, E. V. Babenko, B. V. Afanasev, A. S. Nemkov, G. G. Khubulava
Aineistotyyppi:	Artigo
Kieli:	Russo
Julkaistu:	Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2019-07-01
Sarja:	Вестник трансплантологии и искусственных органов
Aiheet:	coronary artery bypass grafting autologous bone marrow mononuclear cells reperfusion myocardial damage ischemic heart disease diastolic dysfunction of the left ventricular myocardium heart failure clinical study
Linkit:	https://journal.transpl.ru/vtio/article/view/1027
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!